Australia markets closed

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.30000.0000 (0.00%)
At close: 04:00PM EDT
1.3400 +0.04 (+3.08%)
Pre-market: 04:16AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,309
2,916
3,613
2,763
6,044
Cost of revenue
-
-
-
230.097
144.169
Gross profit
-
-
-
2,533
5,900
Operating expenses
Research development
13,858
12,841
10,373
12,454
2,368
Selling general and administrative
6,057
5,138
5,146
4,265
4,717
Total operating expenses
20,430
18,423
15,856
17,367
7,468
Operating income or loss
-18,121
-15,506
-12,243
-14,604
-1,425
Interest expense
103.517
63.012
69.502
128.518
220.173
Total other income/expenses net
-
211.693
-581.128
-84.803
-
Income before tax
-18,536
-15,352
-12,859
-14,781
-1,645
Income tax expense
0
0
0
0
0
Income from continuing operations
-18,536
-15,352
-12,859
-14,781
-1,645
Net income
-18,536
-15,352
-12,859
-14,781
-1,645
Net income available to common shareholders
-18,536
-15,352
-12,859
-14,781
-1,645
Basic EPS
-
-2.70
-2.88
-3.36
-0.42
Diluted EPS
-
-2.70
-2.88
-3.36
-0.42
Basic average shares
-
5,687
4,447
4,405
3,882
Diluted average shares
-
5,687
4,447
4,405
3,882
EBITDA
-
-14,941
-12,410
-14,318
-1,422